Latest Breaking News On - Ionis pharmaceuticals company profile - Page 5 : vimarsana.com

Ionis Pharmaceuticals, Inc (NASDAQ:IONS) Receives $49 07 Consensus Target Price from Analysts

Ionis Pharmaceuticals, Inc (NASDAQ:IONS) Receives $49 07 Consensus Target Price from Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesWilliam blairPatrickr oneilPiper sandlerPeoples bankInsider transactions at ionis pharmaceuticalsHedge funds weigh in on ionis pharmaceuticalsAlmanack investment partnersMorgan stanleyIonis pharmaceuticals incIonis pharmaceuticals company profileNews ratings for ionis pharmaceuticals dailyAnalyst recommendations for ionis pharmaceuticalsIonis pharmaceuticals trading downGoldman sachs groupIonis pharmaceuticals

Privium Fund Management B V Has $10 36 Million Holdings in Ionis Pharmaceuticals, Inc (NASDAQ:IONS)

Privium Fund Management B V Has $10 36 Million Holdings in Ionis Pharmaceuticals, Inc (NASDAQ:IONS)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesC frank bennettPiper sandlerEugene schneiderIonis pharmaceuticals company profileExchange commissionNews ratings for ionis pharmaceuticals dailyIonis pharmaceuticalsNeedham companyRoyal bankAlmanack investment partnersIonis pharmaceuticals incQuarter for ionis pharmaceuticalsHorizon investmentsPrivium fund managementIonis pharmaceuticals price performance

Ionis Pharmaceuticals, Inc (NASDAQ:IONS) is Privium Fund Management B V s 8th Largest Position

Ionis Pharmaceuticals, Inc (NASDAQ:IONS) is Privium Fund Management B V s 8th Largest Position
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesStifel nicolausEugene schneiderElizabethl hougenPiper sandlerHorizon investmentsIonis pharmaceuticals stock performanceQuarter for ionis pharmaceuticalsAlmanack investment partnersIonis pharmaceuticals incRoyal bankGoldman sachs groupPeoples bankSecurities exchange commissionPrivium fund managementNews ratings for ionis pharmaceuticals daily

Ionis Pharmaceuticals (NASDAQ:IONS) Raised to Hold at StockNews com

Ionis Pharmaceuticals (NASDAQ:IONS) Raised to Hold at StockNews com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesElizabethl hougenStifel nicolausRaymond jamesWilliam blairAnalyst recommendations for ionis pharmaceuticalsInsider transactions at ionis pharmaceuticalsGoldman sachs groupIonis pharmaceuticalsIonis pharmaceuticals company profileSecurities exchange commissionInstitutional trading of ionis pharmaceuticalsXponance incNews ratings for ionis pharmaceuticals dailyVictory capital management incBleakley financial group

Ionis Pharmaceuticals (NASDAQ:IONS) Lifted to Hold at StockNews com

Ionis Pharmaceuticals (NASDAQ:IONS) Lifted to Hold at StockNews com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesWilliam blairRaymond jamesRoyal bankAnalyst recommendations for ionis pharmaceuticalsPeoples bankIonis pharmaceuticals company profileGoldman sachs groupIonis pharmaceuticalsInstitutional trading of ionis pharmaceuticalsAlmanack investment partnersNews ratings for ionis pharmaceuticals dailyIonis pharmaceuticals incHorizon investmentsMorgan stanleyIonis pharmaceuticals stock performance